← Leaderboards
John M Chirgwin
Rlr Va Medical Center
$641,670
Attributed
$641,670
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $325.8K · FY2014–24$500K$375K$250K$125K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$641,670 · 1
VA$0 · 2
By mechanism
R01$641,670 · 1
I01$0 · 2
Top collaborators
- Attaya Suvannasankha8 shared
Others in their field
Top investigators on “Osteocytes”
- Brendan Hl Lee · Baylor College Of Medicine$12,111,241
- Mitchell B Schaffler · Mount Sinai School Of Medicine Of Nyu$10,776,075
- Sarah L Dallas · University Of Missouri Kansas City$10,095,218
- Sundeep Khosla · Mayo Clinic Rochester$9,612,446
- Charles A O'Brien · Univ Of Arkansas For Med Scis$9,260,858
- Nicolae Valentin David · Northwestern University$8,342,353
Research focus
OsteocytesMalignant NeoplasmsCellsReceptorOsteogenesisOsteoblastsBoneTumor GrowthBone DiseasesMultiple MyelomaOsteoclastsBone PainMalignant Neoplasm Of LungMalignant Bone NeoplasmMetastatic Neoplasm To The BoneLuciferasesMouse ModelClinical TrialsGrowthBreastBiologyGenesCell LineAutomobile Driving
Grant awards (10)
Manipulating the N-end Rule Protein Degradation Pathway to Build Bone and Decrease Tumor Growth in Multiple Myeloma Bone Disease$315,848
R01 · FY2024 · CA · contact PI
Manipulating the N-end Rule Protein Degradation Pathway to Build Bone and Decrease Tumor Growth in Multiple Myeloma Bone Disease$325,822
R01 · FY2023 · CA · contact PI
A Novel Agent to Suppress Tumor Growth in Bone, Prevent Cachectic Muscle Loss and Preserve Skeletal Integrity$0
I01 · FY2022 · VA · contact PI
A Novel Agent to Suppress Tumor Growth in Bone, Prevent Cachectic Muscle Loss and Preserve Skeletal Integrity$0
I01 · FY2021 · VA · contact PI
A Novel Agent to Suppress Tumor Growth in Bone, Prevent Cachectic Muscle Loss and Preserve Skeletal Integrity$0
I01 · FY2020 · VA · contact PI
A Novel Agent to Suppress Tumor Growth in Bone, Prevent Cachectic Muscle Loss and Preserve Skeletal Integrity$0
I01 · FY2019 · VA · contact PI
Role of Osteocytes in Myeloma Bone Disease$0
I01 · FY2017 · VA · contact PI
Role of Osteocytes in Myeloma Bone Disease$0
I01 · FY2016 · VA · contact PI
Role of Osteocytes in Myeloma Bone Disease$0
I01 · FY2015 · VA · contact PI
Role of Osteocytes in Myeloma Bone Disease$0
I01 · FY2014 · VA · contact PI